Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1
- PMID: 27545623
- DOI: 10.1016/j.str.2016.07.008
Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1
Abstract
Doublecortin-like kinase 1 (DCLK1) is a serine/threonine kinase that belongs to the family of microtubule-associated proteins. Originally identified for its role in neurogenesis, DCLK1 has recently been shown to regulate biological processes outside of the CNS. DCLK1 is among the 15 most common putative driver genes for gastric cancers and is highly mutated across various other human cancers. However, our present understanding of how DCLK1 dysfunction leads to tumorigenesis is limited. Here, we provide evidence that DCLK1 kinase activity negatively regulates microtubule polymerization. We present the crystal structure of the DCLK1 kinase domain at 1.7 Å resolution, providing detailed insight into the ATP-binding site that will serve as a framework for future drug design. This structure also allowed for the mapping of cancer-causing mutations within the kinase domain, suggesting that a loss of kinase function may contribute to tumorigenesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.Mol Cancer. 2014 May 6;13:103. doi: 10.1186/1476-4598-13-103. Mol Cancer. 2014. PMID: 24885928 Free PMC article.
-
Structural Basis of Inhibition of DCLK1 by Ruxolitinib.Int J Mol Sci. 2021 Aug 6;22(16):8488. doi: 10.3390/ijms22168488. Int J Mol Sci. 2021. PMID: 34445192 Free PMC article.
-
STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1.Structure. 2017 Feb 7;25(2):287-294. doi: 10.1016/j.str.2016.12.008. Epub 2017 Jan 12. Structure. 2017. PMID: 28089446 Free PMC article.
-
Functional implication of Dclk1 and Dclk1-expressing cells in cancer.Small GTPases. 2017 Jul 3;8(3):164-171. doi: 10.1080/21541248.2016.1208792. Epub 2016 Jul 26. Small GTPases. 2017. PMID: 27458755 Free PMC article. Review.
-
Role of DCLK1 in oncogenic signaling (Review).Int J Oncol. 2022 Nov;61(5):137. doi: 10.3892/ijo.2022.5427. Epub 2022 Sep 23. Int J Oncol. 2022. PMID: 36148883 Review.
Cited by
-
Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ.Cell Death Differ. 2023 May;30(5):1184-1197. doi: 10.1038/s41418-023-01147-8. Epub 2023 Mar 13. Cell Death Differ. 2023. PMID: 36914767 Free PMC article.
-
Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1.Commun Biol. 2021 Sep 20;4(1):1105. doi: 10.1038/s42003-021-02631-y. Commun Biol. 2021. PMID: 34545159 Free PMC article.
-
A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.Lab Invest. 2017 Oct;97(10):1245-1261. doi: 10.1038/labinvest.2017.40. Epub 2017 Apr 17. Lab Invest. 2017. PMID: 28414327 Free PMC article.
-
DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.Theranostics. 2022 Jul 4;12(12):5258-5271. doi: 10.7150/thno.72037. eCollection 2022. Theranostics. 2022. PMID: 35910805 Free PMC article.
-
Discovery of a selective inhibitor of doublecortin like kinase 1.Nat Chem Biol. 2020 Jun;16(6):635-643. doi: 10.1038/s41589-020-0506-0. Epub 2020 Apr 6. Nat Chem Biol. 2020. PMID: 32251410 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical